Reduction of T-Helper Cell Responses to Recall Antigen Mediated by Codelivery with Peptidoglycan via the Intestinal Nanomineral–Antigen Pathway by Rachel E. Hewitt et al.
March 2017 | Volume 8 | Article 2841
Original research
published: 17 March 2017
doi: 10.3389/fimmu.2017.00284
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Mats Bemark, 
University of Gothenburg, Sweden
Reviewed by: 
Annalisa Ciabattini, 
University of Siena, Italy  
Nicolaas Adrianus Bos, 
University Medical Center Groningen, 
Netherlands
*Correspondence:
Rachel E. Hewitt 
rachel.hewitt@mrc-ewl.cam.ac.uk
Specialty section: 
This article was submitted to 
Mucosal Immunity, 
a section of the journal 
Frontiers in Immunology
Received: 02 November 2016
Accepted: 28 February 2017
Published: 17 March 2017
Citation: 
Hewitt RE, Robertson J, Haas CT, 
Pele LC and Powell JJ (2017) 
Reduction of T-Helper Cell 
Responses to Recall Antigen 
Mediated by Codelivery with 
Peptidoglycan via the Intestinal 
Nanomineral–Antigen Pathway. 
Front. Immunol. 8:284. 
doi: 10.3389/fimmu.2017.00284
reduction of T-helper cell 
responses to recall antigen 
Mediated by codelivery with 
Peptidoglycan via the intestinal 
nanomineral–antigen Pathway
Rachel E. Hewitt1,2*, Jack Robertson2, Carolin T. Haas2, Laetitia C. Pele2 and  
Jonathan J. Powell1,2
1 Department of Veterinary Medicine, University of Cambridge, Cambridge, UK, 2 Medical Research Council, Department of 
Mineral Science and Technology, Elsie Widdowson Laboratory, Cambridge, UK
Naturally occurring intestinal nanomineral particles constituently form in the mammalian 
gut and trap luminal protein and microbial components. These cargo loaded nanomi-
nerals are actively scavenged by M cells of intestinal immune follicles, such as Peyer’s 
patches and are passed to antigen-presenting cells. Using peripheral blood mononuclear 
cell populations as an in vitro model of nanomineral uptake and antigen presentation, 
we show that monocytes avidly phagocytose nanomineral particles bearing antigen 
and peptidoglycan (PGN), and that the presence of PGN within particles downregulates 
their cell surface MHC class II and upregulates programmed death receptor ligand 1. 
Nanomineral delivery of antigen suppresses antigen-specific CD4+ T  cell responses, 
an effect that is enhanced in the presence of PGN. Blocking the interleukin-10 receptor 
restores CD4+ T cell responses to antigen codelivered with PGN in nanomineral form. 
Using human intestinal specimens, we have shown that the in vivo nanomineral pathway 
operates in an interleukin-10 rich environment. Consequently, the delivery of a dual 
antigen–PGN cargo by endogenous nanomineral in vivo is likely to be important in the 
establishment of intestinal tolerance, while their synthetic mimetics present a potential 
delivery system for therapeutic applications targeting the modulation of Peyer’s patch 
T cell responses.
Keywords: nanomineral, T cells, intestinal tolerance, peptidoglycan, il-10, antigen-presenting cells, programmed 
death receptor ligand 1
inTrODUcTiOn
A purposeful role for endogenously formed nanomineral particles of the intestine, serving as 
natural transfection agents, was proposed over a decade ago, arising from studies on the influence 
of particulates in intestinal disease (1). Naturally forming intestinal nanominerals have recently 
been characterized as nano-sized amorphous magnesium-substituted calcium phosphate (AMCP) 
species, constituently formed through self-assembly in the milieu of the intestinal lumen (2). These 
particles comprise a blend of nanomineral, protein, and microbial components such as peptidoglycan 
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(PGN). Self-assembly of intestinal nanomineral is conserved 
under significant calcium and phosphate dietary deficiency in 
mice, signifying that formation of particles in the intestine may 
occur for physiological benefit (2). The occurrence of nanomin-
eral particles traversing specialized microfold “M” cells into 
intestinal lymphoid aggregates such as Peyer’s patches, coupled 
with their appearance within antigen-presenting cells (APCs), 
advocates an antigen “shuttling” function of these particles (2). 
In situ studies of intestinal lymphoid tissue have revealed that the 
immuno-inhibitory receptor, programmed death receptor ligand 
1 (PD-L1), is heavily upregulated on cells that have received 
nanomineral-mediated delivery of PGN, suggesting that these 
nanomineral particles may have a role in the maintenance of 
intestinal tolerance toward gut derived antigen and microbiota 
in the healthy gut (2).
Microbial components, such as PGN, are recognized by cel-
lular pattern-recognition receptors (PRRs), including toll-like 
receptors (TLRs) and NOD-like receptors (3). Nanoparticulate 
carriage of antigen, especially when combined with PRR ligands is 
normally associated with the enhancement of immune responses, 
and, therefore, nanoparticles have been broadly utilized in vac-
cine strategies (4–6). PRR recognition of microbial components 
triggers innate immune processes, but also facilitate the develop-
ment of adaptive immune responses. This is enabled through the 
secretion of cytokines, the modulation of regulatory receptors 
(such as members of the B7 superfamily), and the stimulation 
of antigen processing and presentation by APCs (3, 7–9). As well 
as facilitating robust immune responses, the tolerance-inducing 
nature of some PRR ligands has also been established under 
certain circumstances (10–13). The expression of PRRs occurs 
in many cell types throughout the intestine, with numerous 
roles, including promoting the production of factors associated 
with tissue homeostasis, luminal sampling, and the development 
of specific cell subsets (14, 15). In the intestine, recognition of 
resident microbiota via PRRs appears a seminal feature in the 
maintenance of tolerance in the healthy gut, while failure in such 
processes may be involved in the development of inflammatory 
disease (14–18). The importance of PRRs in intestinal tolerance 
is emphasized by mouse studies, where negating TLR2, TLR4, 
or the corresponding signaling components results in aberrant 
immune responses and gut injury (14). Similarly in humans, 
defects in the bacterial sensing receptor NOD-2 are associated 
with the intestinal inflammatory disorder Crohn’s disease (CD), 
characterized as activated APC interacting with a dominant 
CD4+ Th1 lymphocyte population (19).
The recent discovery of endogenous intestinal nanominerals 
traversing into nearby lymphoid tissue, followed by uptake by 
APCs offers a novel, additional route by which luminal antigen 
and components of intestinal microbiota may be continually 
sampled. In the intestine, nanomineral AMCP particles were 
found to be colocalized with dietary antigen and PGN, a microbial 
component ubiquitous in the intestinal tract (2). Further in vitro 
studies using synthetic mimetics of endogenous AMCP particles 
(sAMCP) demonstrated a marked capacity of sAMCP to trap and 
deliver macromolecules which were then delivered to endosomal/
lysosomal compartments upon uptake by APCs. Furthermore, 
the sAMCP construct itself failed to either significantly alter 
gene regulation of APCs in response to PGN challenge or to 
alone induce innate inflammatory responses (20). In this study, 
we establish APC responsiveness to protein antigen and PGN 
delivered as nanomineral cargo, as found in the intestine, and the 
subsequent influence on T helper cell responses. Synthetic AMCP 
was loaded with PGN and antigenic protein. PGN was chosen as 
the model PRR ligand due to its presence in the intestinal lumen, 
both as a component of the bacterial cell wall, particularly in 
Gram-positive bacteria, and as cell wall fragments released from 
commensal bacteria. By mimicking the attributes of intestinal 
nanomineral particles (20), we demonstrate in vitro suppression 
of antigen-specific CD4+ Th1 cell responses to cognate antigen 
thereby supporting a role for the nanomineral–antigen pathway 
in the control and maintenance of immune responsiveness in the 
gut and the use of nanomineral mimetics for the modulation of 
antigen-specific T cell responses.
MaTerials anD MeThODs
The study was approved by the local ethics committee; University 
of Cambridge, Human Biology Research Ethics Committee, 
application HBREC.2015.10.
Particle synthesis
Synthetic amorphous magnesium-substituted calcium phosphate 
(sAMCP) nanomineral particles were prepared as previously 
described (20). Briefly, for the preparation of particles incor-
porating PGN (Staphylococcus aureus, Fluka), PGN was added 
to phosphate (PO4) solution [containing 39  mM (NH4)HPO4 
(Sigma-Aldrich) in 0.15 M TRIS buffer, adjusted to pH 8 with 
hydrochloric acid], prior to mixing in equal parts with calcium–
magnesium–BSA solution (BSA; Sigma-Aldrich Company Ltd., 
Dorset, UK) dissolved in a Ca/Mg solution [containing 35 mM 
CaCl2 (Sigma-Aldrich), 7.2 mM MgCl2 (Sigma-Aldrich) in 0.15 M 
Tris buffer (Sigma-Aldrich)] at 1 mg/mL for a final PGN concen-
tration of 50 μg/mL mixed solution. For particles incorporating 
protein purified derivative (PPD) of tuberculin (Statens Serum 
Institute, Denmark), PPD was added to the phosphate solution 
prior to mixing with the calcium–magnesium–BSA solution for 
a final PPD concentration of 100 μg/mL, which was then incu-
bated with gentle rotation at room temperature for 1 h to allow 
particle formation. Particles were precipitated by centrifugation 
(1,500 rpm for 5 min), washed in pH 10 water, followed by wash-
ing in tissue culture grade water before re-suspending in tissue 
culture media at half of the original particle solution volume.
nanosight ns500 analysis
Size distribution of amorphous calcium phosphate particles was 
examined using a Nanosight NS500 instrument and NTA 2.1 
software (NanoSight Ltd.). Freshly synthesized particles were 
diluted 1:10 to an optimal particle concentration of between 107 
and 109 particles/mL immediately prior to loading into the view-
ing chamber. Camera levels and focus were adjusted for optimal 
particle visualization and tracking. A capture duration of 90  s 
was used to record each video for NTA analysis. Mode values 
were obtained through area-under-curve analysis in GraphPad 
Prism 6.03 while average size and percentiles were determined in 
TaBle 1 | Details of patients from whom ileal tissue specimens were 
analyzed.
gender age Diagnosis
Female 61 Adenocarcinoma of colon
Male 76 Tumor of ileum, carcinoid
Female 65 Tumor of ileum, carcinoid
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Microsoft Excel. For the latter, data were transformed into cumu-
lative percentage and exact D10, D50, and D90 values calculated 
with linear interpolation using the two data points above and 
below the 10th, 50th, and 90th percentile, respectively.
Quantification of Organic Matter within 
Particles
Following synthesis, empty particles or particles containing BSA, 
PPD, and PGN (alone or in conjunction) were centrifuged at 
1,500  rpm (5  min) and supernatants were collected. After fur-
ther washing twice, in pH 10 water, particles were dissolved in 
100 mM citric acid buffer (pH 3) to release the organic material. 
Total protein content was measured using the Bradford protein 
assay (as per manufacturer’s protocol, Bio-Rad Laboratories, UK) 
while PGN matter was quantified using both a colorimetric assay 
and a modified Periodic Acid Schiff (PAS) assay as described (21).
Colorimetric Assay
For quantification of crude PGN present within the particles, 
dyeing of PGN with Remazol Blue Brilliant (RBB; Sigma) was 
undertaken (22). Briefly, 10  mg PGN were mixed with 1  mL 
0.25  M NaOH containing 0.02M RBB and the resulting sus-
pension rotated for the first 6  h at 37°C and overnight at 4°C. 
The dyed PGN was then washed in cell culture water until the 
supernatant ran clear to remove excess un-bound RBB. Lysates 
and supernatant of particles that were prepared using the dyed 
PGN were read at 595 nm and PGN concentration determined 
against standard curves of dyed PGN (0–500 μg/mL) prepared in 
the supernatant or lysate of ACP/BSA particles to match sample 
matrices.
PAS Assay
Since PPD contains residual bacterial polysaccharides, quantifi-
cation of PPD incorporation was assessed by the modified PAS 
assay which relies on the formation of a purple complex whose 
absorbance is proportional to the amount of polysaccharide in 
solution. Samples and standards (100 μL) were first incubated 
with 92 mM sodium periodate in 0.5 M sulfuric acid and then 
with 2.7% sodium arsenite in 0.68 M HCl at room temperature on 
a plate shaker (40 min). Following the addition of Schiff ’s reagent 
(Merck KGaA, Germany) and a further 30  min incubation at 
37°C, the plate was read at 540 nm. Concentration of polysac-
charides was determined against a standard curve using PDD 
(0–250 μg/mL) and prepared in the lysate of AMCP particles to 
account for sample matrix.
immunohistochemistry and confocal 
Microscopy
Anonymized, snap frozen human ileal tissue specimens, contain-
ing lymphoid patches, were purchased from a commercial tissue 
bank (Tissue Solutions, UK) and held for use by the authors under 
HTA license agreement 12383. Samples were from the normal 
resection margins of three patients with tumors (Table 1). Tissue 
sections were cryo-sectioned at 14 μm thickness, collected on 
SuperFrost® slides (Thermo Scientific, USA) and allowed to air 
dry for 30 min at room temperature.
Tissue sections were fixed in formaldehyde (Sigma-Aldrich, 
UK) and blocked (10% v/v goat serum, 2% w/v BSA, 0.3  M 
Glycine). Sections were then incubated with the primary anti-
body against human IL-10 (ab34843; Abcam, UK), followed by 
incubation with a secondary antibody (Alexa Fluor® 568 Goat 
Anti-rabbit IgG [H +  L], Invitrogen, UK) and stained for the 
nanomineral using 0.01 M calcein (Sigma-Aldrich, UK). Finally, 
the nuclei were counterstained with Hoescht 33342 (H1399, 
Invitrogen, UK). Sections were imaged with a Leica DMIRE2 
microscope (Leica Microsystems, Germany) at 405, 488, or 
568 nm, fitted with diode, Ar/ArKr, and HeNe lasers, using a 63×, 
1.2 NA water objective lens. Data were recorded using the Leica 
Confocal Software (v2.61) and images processed using Imaris 
version 8.0.0 (Bitplane, UK). Data were collected as 8-bit gray 
scale images and assigned appropriate colors subsequently.
cell isolation, stimulation, and cytokine 
analysis
The human blood cells obtained for this study were single leu-
kocyte cones purchased from the National Blood Service (UK), 
peripheral blood mononuclear cells (PBMC) were isolated using 
density gradient centrifugation. Following isolation, PBMC 
populations were sometimes then stored (in the short term) at 
−80°C until required. Cell stimulation and incubations were 
carried out at 106 cells/mL in RPMI 1640 Media (Sigma-Aldrich) 
containing 10% fetal calf serum (FCS) (PAA Laboratories), 
100  U/mL penicillin, 100 μg/mL streptomycin, and 2  mmol/L 
l-glutamine (all Sigma-Aldrich), and incubated at 37°C, with 5% 
CO2. Soluble stimulants were added at concentrations of 5 μg/
mL PGN (S. aureus, Fluka) and/or 10 μg/mL PPD of tuberculin 
(Statens Serum Institute #2391, Denmark). Controls included 
50 μg/mL BSA in PBS (low endotoxin, Sigma-Aldrich) and 1 μg/
mL staphylococcal enterotoxin B (positive T cell assay control; 
Sigma-Aldrich, data not shown). All particulate stimulations 
were performed by re-suspending 100 μL of freshly synthesized 
particles in cell culture media containing 106 cells/mL. For 
cell incubations above 3  h, cells were washed with RPMI and 
replenished with fresh media (only) and returned to 37°C for 
the remaining period of incubation. After incubation, cells were 
centrifuged at 1,500 rpm for 5 min to pellet cells and the superna-
tant was removed and stored frozen at −80°C until multi-analyte 
analysis performed by Myriad RBM (Austin, TX, USA), or ELISA 
according to manufacturers’ instructions (R&D Systems Europe 
Ltd., Abingdon, UK).
Flow cytometric assays
For surface marker staining, at the end of the incubation 
period, cells were centrifuged at 1,500 rpm for 5 min to pellet 
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cells and the supernatant removed. The cell pellet was stained 
with either anti-PD-L1 FITC, PD-L2 PE, and CD14 PerCP 
Cy5.5, for costimulatory panels or human leukocyte antigen 
(HLA)-DR FITC and CD14 PerCP Cy5.5 (all BD Biosciences, 
UK) according to manufacturers’ instructions for 20–40  min 
on ice in the dark. Cells were then washed with ice cold PBS 
1% BSA, re-suspended in a small volume of PBS containing 1% 
PFA and placed on ice in the dark until acquisition. Single stain 
compensation tubes for each stain used, as well as an unstained 
tube, were also prepared from cell samples at this time in order 
to compensate for spectral overlap. Cells were filtered immedi-
ately prior to acquisition on a Cyan-ADP flow cytometer using 
Summit V4.3.02 software for acquisition and Summit V4.3 
for analysis (Beckman Coulter, UK), acquiring a minimum of 
250,000 events per sample.
For flow cytometric analysis of particle internalization, par-
ticles were prepared as described with the addition of 1 μL of 
10 mg/mL Calcein stock solution (Sigma-Aldrich, UK) added 
to the phosphate solution prior to mixing for each milliliter 
of mixed solution. Mixed solutions were protected from light 
thereon and further incubated with rotation at room tempera-
ture for 1 h followed by the normal centrifugation and washing 
once in tissue culture grade water. Then, 100 μL of fluorescently 
tagged particles (~1.2 ×  108 to 1.6 ×  108 particles/mL) were 
added to 106 cells and incubated for 3  h, before washing and 
re-suspending the cells in ~200 μL ice cold PBS 1% BSA. Cells 
were then stained for 20 min on ice in the dark for CD14 PerCP 
Cy5.5 (BD Biosciences, UK) and CD3 Vio-Green (Miltenyi 
Biotec, UK).
Proliferation assays were carried out as previously described 
(23). Prior to stimulation, PBMC were stained at 2 × 106/mL with 
0.1 μM CFSE (Sigma-Aldrich) diluted in sterile PBS, for 7 min at 
37°C in the dark and then washed three times with RPMI 1640 
containing 20% FCS. From then onward cells were protected 
from light. CFSE-stained PBMC (1 × 106 cells/mL) were trans-
ferred into FACS tubes and incubated with relevant stimulants 
as described. On day 5, cells were washed and stained for the 
surface markers CD3 PE Cy5 and CD4 PE (BD Biosciences, UK) 
according to manufacturers’ instructions; 500,000 events were 
acquired for each sample as described previously.
Flow imaging analysis
For Imagestream analysis of particle internalization, particles 
were synthesized to incorporate calcein, PPD, and PGN as previ-
ously described. A 100 μL of fluorescently tagged particles were 
added to 106 cells/mL and incubated for 3 h, before washing and 
re-suspending cells in ice cold PBS at 107 cells in 100 μL. Cells 
were then stained for 20 min on ice in the dark for the surface 
marker CD14 PerCP Cy5.5 (BD Biosciences, UK), washed, re-
suspended in a small volume of PBS, and filtered before acquisi-
tion on an ImagestreamX using INSPIRE V4.1.501.0 software 
(Amnis-Merck Millipore, USA), acquiring a minimum of 50,000 
events per sample. A stained particle control was incubated with 
cells and acquired in addition to unstained particle/cell negative 
controls and single surface marker controls required for the 
generation of a compensation matrix and analysis using IDEAS 
V6.0 software (Amnis-Merck Millipore, USA).
statistical analysis
Statistical evaluation where multiple comparisons were per-
formed were assessed by one way ANOVA and post hoc analysis 
using Tukey’s honestly significant difference method with signifi-
cance taken as P = < 0.05 (particle uptake, induction of surface 
receptor expression, cytokine production, and T  cell prolifera-
tion). Only statistically relevant differences are discussed in the 
text. Experiments comparing two datasets were performed using 
paired, Student’s t-test. P = <  0.05 was considered statistically 
significant.
resUlTs
size and loading of synthetic aMcP
To examine the influence of synthetic AMCP (sAMCP) antigen 
carriage on CD4+ antigen-specific T  cell responses, sAMCP 
particles were synthesized and characterized as recently 
reported (20), but in the presence of PPD of tuberculin from 
Mycobacterium tuberculosis. Resulting particle size distribu-
tion, assessed using nanoparticle tracking analysis, revealed 
a hydrodynamic size (D10–D90) ranging from 67 to 320 nm, 
a D50 of ~185  nm and peak sizes of about 130 and 210  nm 
(Figure 1A; Table 2). In some experiments, sAMCP particles 
were also synthesized to additionally incorporate the bacterial 
component PGN together with PPD and nanoparticle track-
ing analysis confirmed that this did not significantly alter the 
particle size range (i.e., D10–D90: 55–350  nm and D50 of 
174  nm, Figure  1B; Table  2, peak sizes of 140 and 270  nm). 
Thus, overall, sAMCP bearing PPD or PPD together with PGN 
combined within the same particles demonstrated a similar 
size range to the naturally occurring endogenous nanomineral 
(2) (i.e., 75–150 nm) with a small proportion reaching larger 
agglomerates of ~350 nm, as recently detailed for sAMCP with 
ovalbumin incorporation (20). The extent of incorporation of 
PPD antigen was quantified using the PAS assay while trapping 
of RBB-dyed PGN was assessed directly using colorimetry. 
With this protocol, sAMCP incorporated around 50% of the 
total PPD and 90% of the total PGN added during synthesis 
(Figure  1C). Taken together these data demonstrated high 
particle loading of our reporter protein antigen (PPD) while 
maintaining intestinal particle characteristics and size range. 
In subsequent stimulation assays, particle concentrations were 
adjusted such that PBMC were exposed to final concentration 
of ~10 μg/mL PPD and PGN.
Delivery of Protein antigen in synthetic 
aMcP reduces cD4+ T cell responses
In vivo, endogenously formed AMCP nanoparticles deliver lumi-
nal antigen to gut tissue APCs (2). We first sought to examine 
whether AMCP delivery of antigen influences antigen-specific 
T cell responses, compared to APC uptake of the same antigen 
in soluble form. For this we adapted methods described by Singh 
and Booth, using the MHC class II and costimulation dependant 
CD4+ T cell recall antigen PPD to examine antigen-specific T cell 
responses (24). In brief, interferon-gamma (IFN-γ) production 
and proliferation of CD4+ T cells within PBMC of PPD-responding 
TaBle 2 | Descriptive statistics of the synthetic aMcP particle size 
distributions measured by nanoparticle tracking analysis.
D10 (nm; 
n = 3 ± sD)
D50 (nm; 
n = 3 ± sD)
D90 (nm; 
n = 3 ± sD)
average (nm; 
n = 3 ± sD)
sAMCP/PPD 67 ± 7 184 ± 7 321 ± 38 181 ± 9
sAMCP/PPD/
PGN
55 ± 5 174 ± 1 349 ± 28 193 ± 8
sAMCP/PPD: synthetic amorphous calcium phosphate with a model protein (bovine 
serum albumin) and recall antigen protein purified derivative (PPD) incorporated.
sAMCP/PPD/PGN: synthetic AMCP/PPD with the further incorporation of 
peptidoglycan.
D10, D50, and D90 are sizes calculated with linear interpolation using the two data 
points above and below the 10th, 50th, and 90th percentile, respectively.
See Section “Materials and Methods” for detailed synthesis.
FigUre 1 | synthetic aMcP nanomineral characterization of size and 
protein incorporation. (a) Size distributions of sAMCP synthesized to 
incorporate whole protein purified derivative (PPD) antigen and (B) sAMCP 
synthesized to incorporate whole PPD antigen and peptidoglycan (PGN). 
Data are shown as average of three independent experiments and are 
displayed as cumulative particle number (E6/mL) per size interval (i.e., every 
10 nm). (c) Percentage of BSA, PPD, and PGN nanomineral particle 
incorporation.
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donors was measured at 5 days of culture, after a 3 h stimulation 
of the PBMC with soluble or sAMCP-incorporated PPD.
Synthetic AMCP carriage of PPD, failed to induce either robust 
secretion of IFN-γ or CD4+ T cell proliferation in PBMC of PPD-
responding donors, despite matched loading of nanominerals 
with the soluble PPD dose. By contrast, exposure to soluble PPD 
induced both a strong IFN-γ response and proliferation of CD4+ 
T cells (Figures 2A–C). The reduction of T cell responses, when 
sAMCP-incorporated antigen was taken up by APCs, was not 
restricted to PPD as the same result was observed with Tetanus 
Toxoid (Figure S1 in Supplementary Material). These findings 
were unexpected as we have previously shown that sAMCP is an 
effective delivery vehicle for APCs, is inert itself, releases its cargo 
intracellularly, and does not attenuate responsiveness to PGN at 
the gene level (20). We therefore investigated the uptake of, and 
CD4+ T cell responsiveness, toward sAMCP particles containing 
both PPD and PGN.
immune responsiveness to saMcP Dual 
antigen-Peptidoglycan carriage
First, we examined the efficiency of uptake of PPD + PGN-loaded 
sAMCP by APCs present in PBMC. Synthetic AMCP particles 
were synthesized as described in the previous sections, but in the 
presence of the fluorescent marker calcein (20), and loaded with 
PPD and/or PGN. Control sAMCP particles were loaded with 
BSA only. All particles were incubated with PBMC for 3 h. Using 
flow cytometry and flow imaging techniques internalization of 
sAMCP was assessed in both CD3+ T lymphocytes and CD14+ 
monocytes. Calcein+ particle staining, representing AMCP 
uptake, corresponded almost exclusively with cells of the mono-
cytic lineage. Almost 60% of CD14+ monocyte/macrophage cells 
were positive for calcein after 3 h sAMCP exposure, compared to 
less than 1% of the CD3+ lymphocyte population (Figure 3). Flow 
imaging confirmed that sAMCP–PPD–PGN particles were taken 
up more readily than sAMCP control particles (sAMCP–BSA), 
and that the particles were not just associated with monocytes 
but were internalized, with 51.1 ± 10.5% SEM defined as highly 
internalized, visualized residing well within the CD14-defined 
cell membrane boundary (Figure 4).
As well as being pro-inflammatory, under certain circum-
stances PGN is known to play important roles in countering 
inflammatory responses and inducing tolerogenic responses 
through the secretion of IL-10 and the expression of PD-L1 
by APCs (10, 13, 25–28). Hence, we next studied the effects of 
sAMCP-delivered PPD/PGN on primary PBMC cultures in 
terms of (i) the induction of the cell surface regulatory corecep-
tors PD-L1 and PD-L2, (ii) IL-10 secretion, and (iii) modulation 
of the HLA which is associated with MHC class II presentation of 
exogenously derived antigen. The delivery of PPD in AMCP form 
(but not in suspension) increased PD-L1 expression by CD14+ 
APCs. As anticipated (and in agreement with previous studies 
where PGN was present in suspension), the addition of PGN also 
FigUre 2 | antigen-specific cD4+ T cell proliferation and interferon (iFn) gamma secretion in response to soluble and saMcP antigen carriage.  
(a) Boxplots displaying IFN gamma present in supernatants from peripheral blood mononuclear cells (PBMC) at day 5 in response to protein purified derivative 
(PPD) and nanomineral carried PPD (sAMCP–PPD) [n = 5 PPD responder donors, δ indicates significant difference from the control (assessed by one way ANOVA 
and post hoc analysis using Tukey’s honestly significant difference method, significance taken as P = < 0.05)]. Boxplot whiskers were set at 1.5 × interquartile range 
(IQR) above the third quartile and 1.5 × IQR below the first quartile, minimum or maximum values that have fallen outside this range are shown as outliers (small 
black dots). (B) Boxplots displaying the percentage proliferation of CD4+CD3+ T cells in PBMC at day 5 in response to soluble PPD (PPD) and nanomineral carried 
PPD (sAMCP–PPD) (n = 5 PPD responder donors, δ P = 0.02 PPD versus sAMCP–PPD in a paired Student’s t-test). (c) Example flow cytometric plots showing 
CD4+CD3+ dividing cells (CFSE low) in a CFSE proliferation assay; cells within the lymphocyte gate were gated for CD4 and plotted as CD3 versus CFSE.
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stimulated the expression of PD-L1, but not PD-L2, by the APCs 
and additionally stimulated IL-10 secretion (Figures  5A,B). 
Furthermore, cell surface expression of the MHC class II antigen 
presenting molecule, HLA-DR, was significantly increased on 
APCs in response to PPD by 24 h only when PGN was absent 
(Figure 5C).
We therefore considered the mechanism by which intracel-
lular delivery to APCs of PGN plus PPD antigen could influence 
the proliferation of antigen-responding T  cells within PBMC 
derived from a further six healthy, PPD-responding, donors. 
Antigen-specific CD4+ T  cell proliferation assays were per-
formed as before (Figure 2) but with the addition of blocking 
antibodies against either PD-L1 or the IL-10 receptor (IL-10r). 
Consistent with our previous results, delivery of PPD in sAMCP 
reduced CD4+ T  cell proliferation, and this inhibition was 
further enhanced when PGN was present (Figure 6). Blocking 
the IL-10r and hence inhibiting IL-10 activity restored T  cell 
proliferation, whereas the neutralization of PD-L1 had no such 
effect (Figure  6). Taken together our data show that multiple 
checkpoints appear to inhibit T cell proliferation in response to 
sAMCP-delivered antigen. First, the nanomineral itself does not 
permit efficient protein presentation for T cell proliferation in 
comparison to delivery of free protein. Second, the concomitant 
carriage of PGN, which occurs in  vivo, reduces the available 
HLA-DR on the surface of the APC thereby limiting antigen 
presentation via the effect of IL-10 production. Finally, antigen 
that is presented occurs in the context of immuno-inhibitory 
PD-L1 (Figure 5).
These studies indicated that the secretion of IL-10 provided 
the most striking attenuation of antigen-specific CD4 T  cell 
proliferation in response to nanomineral carried PPD–PGN. 
To verify the physiological relevance of these observations, we 
therefore sought to confirm that AMCP nanomineral-bearing 
cells in the Peyer’s patch sub-epithelial dome (SED) exist in 
an IL-10 high environment. Samples of human tissue, from 
three patients, containing Peyer’s patches were collected from 
the uninvolved margins of surgically resected intestinal speci-
mens. AMCP+ cells of the SED region were detected by calcein 
FigUre 3 | synthetic aMcP nanomineral uptake by cD14+ cell populations present in peripheral blood mononuclear cells (PBMc). Flow cytometric 
measurement of fluorescently labeled particles in association with (a) lymphocyte and (B) monocyte gated populations plotted as either CD3 or CD14 versus 
calcein (full gating strategy is shown in Figure S2 in Supplementary Material). Representative flow plots from one subject are shown in response to incubation with 
particles containing BSA, PPD, or PPD and peptidoglycan (PGN) are shown. (c) Bar chart showing percentage of calcein+ cells in lymphocyte (CD3+, black fill) and 
monocyte (CD14+, gray fill) populations within PBMC derived from five healthy individuals. δ indicates significant difference from the control (assessed by one way 
ANOVA and post hoc analysis using Tukey’s honestly significant difference method, significance taken as P = < 0.05).
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staining and IL-10 protein was detected by specific antibody-
based staining. Consistent with previous reports, all specimens 
showed clear calcein staining in the SED representing the pres-
ence of AMCP (29). In addition, IL-10 staining was strongly 
positive in the same area compared to the rest of the patch 
(Figure 7). Thus, our findings imply that the failure to induce 
antigen-specific CD4 T  cell proliferation, observed in  vitro 
in response to antigen and PGN codelivered to APCs within 
sAMCP nanomineral, is of physiological relevance in vivo as the 
key attenuating molecule (IL-10) appears abundantly present in 
close proximity to AMCP.
DiscUssiOn
Antigen-presenting cell interactions with microbiota are of sub-
stantial importance in maintaining the balance between tolerance 
and immunity in the gut (14–18). The discovery of endogenous 
intestinal nanominerals offers an additional route by which 
luminal antigen and components of intestinal microbiota may be 
continually sampled. Nanomineral carriers of luminal compo-
nents are well placed to play a role in the microbiota—immune 
system dialog (2). Using an in  vitro PBMC-based framework 
we have examined the influence of an intestinal nanomineral 
mimetic in a manner that will inform future in  vivo studies. 
Consistent with other reports of uptake of nano-sized materials 
(30, 31), the nanomineral mimetic was rapidly sequestered by 
professional phagocytes within PBMC irrespective of cargo. We 
previously hypothesized that the nanomineral pathway might 
ensure tolerogenic signaling in association with harmless lumi-
nal derived antigen, by facilitating the codelivery of antigen with 
mucosal bacterial components such as PGN (2). In the unique 
environment of the gut, this might ensure that adaptive immune 
responses to “harmless antigen” are not overly dominant, while 
retaining the opportunity for protective immune responses 
if the same antigen were identified in a different context (i.e., 
without codelivery). We now show that synthetic mimetics of 
intestinal nanomineral carriers loaded with antigen and PGN 
are themselves capable of attenuating CD4+ T  cell responses, 
resulting in reduced T  cell proliferation to a cognate recall 
antigen, and do not simply rely upon a hypo-responsive envi-
ronment (such as the gut) for this effect. We demonstrated the 
PGN promotion of blood derived monocytes into a phenotype 
less suited to the promotion of Th1 type CD4+ T cell responses, 
augmented by the dual delivery of antigen and PGN to APCs 
by sAMCP, chiefly regulated by the secretion of IL-10, a classi-
cally anti-inflammatory cytokine. Several murine studies have 
reported the occurrence of IL-10 secreting APC populations in 
the maintenance of intestinal tolerance, especially pertaining 
to the lamina propria and Peyer’s patches (32–38). Although 
human studies are considerably more limited, IL-10 production 
FigUre 4 | synthetic aMcP nanomineral internalization by cD14+ cell populations present in peripheral blood mononuclear cells (PBMc). 
ImagestreamX analysis of particle internalization. (a) Boxplots showing the percentage of calcein+CD14+ within PBMC from five healthy donors (P = 0.01 sAMCP 
versus sAMCP–PPD–peptidoglycan (PGN) in a paired Student’s t-test). Cells residing in the CD14+calcein+ double positive gate shown were assessed for the degree 
of particle internalization (defined as calcein fluorescence residing within the CD14 fluorescence marking the cell wall boundary), cell gates are shown in panel (B), 
full gating strategy is shown in Figure S3 in Supplementary Material. (c) Example images of CD14+calcein+ cells residing within the high internalization gate are 
shown. For boxplots, whiskers were set at 1.5 × interquartile range (IQR) above the third quartile and 1.5 × IQR below the first quartile, minimum or maximum values 
that have fallen outside this range are shown as outliers (small black dots).
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has also been identified by ELISPOT and RT-PCR analysis of 
mononuclear cells freshly isolated from human Peyer’s patch 
biopsies (39). In vivo, it is possible that IL-10 production may be 
exclusive to AMCP recipient APCs or additionally sustained by 
the subsequent generation or stimulation of regulatory T cells. 
Early exposure to TLR agonists has previously been demon-
strated in  vitro to block the differentiation of monocytes into 
mature APC, resulting in a PD-L1+ tolerogenic APC phenotype, 
which fail to induce Th1  cell proliferation, instead inducing 
regulatory T cells (10). Tolerogenic, regulatory T cell inducing 
macrophage subsets have similarly been reported to reside in 
both the lamina propria and Peyer’s patches of mice (34–36, 
38). Further work should therefore consider the role of AMCP 
on the influence of T cell responsiveness and the generation of 
IL-10 and regulatory T cells in vivo, both of which could drive a 
tolerogenic response.
FigUre 5 | The influence of synthetic aMcP on programmed death receptor ligand 1 (PD-l1), PD-l2, il-10 secretion, and Mhc class ii 
expression. (a) Changes in the surface expression of PD-L1 (no fill) and PD-L2 (gray fill) on CD14+ gated monocytic cells present within peripheral blood 
mononuclear cells (PBMC), data from six donors CD14+ cell responses to all stimulants tested are shown (example histogram plots from one donor are shown in 
Figure S4 in Supplementary Material). (B) IL-10 present in supernatants of PBMC day 5 after stimulation, averaged data from six donors are shown. (c) Median 
fluorescence intensity of HLA-DR surface expression over time after PPD and nanomineral PPD (sAMCP–PPD) or nanomineral PPD/peptidoglycan (PGN) 
(sAMCP–PPD–PGN) stimulation, averaged data (±SEM) from five donors are shown. δ indicates significant difference from the control (assessed by one way 
ANOVA and post hoc analysis using Tukey’s honestly significant difference method, significance taken as P = < 0.05). For boxplots, whiskers were set at 
1.5 × interquartile range (IQR) above the third quartile and 1.5 × IQR below the first quartile, minimum or maximum values that have fallen outside this range are 
shown as outliers (small black dots).
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Parallels exist between naturally forming intestinal nanomin-
erals and nanoparticulate calcium phosphate vaccine prepara-
tions. Both possess distinctly adventitious carriage and targeted 
delivery of antigen simultaneously with additional immune 
modulators to cells with professional antigen-presenting abil-
ity. Calcium phosphate nanoparticulate species are generally 
understood to adsorb biological materials well and have been 
used as adjuvants reported to enhance immune responses (40, 
41). As naturally occurring compounds, calcium phosphate 
species are considered to be well tolerated with few side effects 
and have additionally been utilized as vectors for gene delivery 
(42). We found that loading sAMCP with PPD antigen alone (i.e., 
without PGN) led to significantly reduced CD4 T cell responses. 
A possible explanation for the failure of T  cell responsiveness 
FigUre 6 | antigen-specific cD4+ T cell proliferation in response to saMcP codelivery of antigen and peptidoglycan (Pgn). (a) Example flow 
cytometric plots of CD4+CD3+ gated T cells within peripheral blood mononuclear cells (PBMC) showing CFSE dilution. For analysis, an extended lymphocyte gate 
was drawn based on the forward and side scatter profiles of lymphocytes within PBMC, followed by a CD4+ gate and subsequent CD3 gate. CD3+CD4+ cells were 
then finally plotted as CD3 versus CFSE and a quadrant drawn based on the negative control to measure the percentage of dividing (CFSE low) cells in response to 
antigen-specific stimulation. Example analysis plots of responses from one donor are shown. (B) Boxplots displaying percentage of divided CD4+CD3+ T cells at day 
5 after stimulation with PPD, nanomineral PPD (sAMCP–PPD), or nanomineral PPD/PGN (sAMCP–PPD–PGN), with or without blocking antibodies for programmed 
death receptor ligand 1 (PD-L1) or the IL-10 receptor (n = 6 PPD responders). δ indicates significant difference from the control (assessed by one way ANOVA and 
post hoc analysis using Tukey’s honestly significant difference method, significance taken as P = < 0.05). For boxplots, whiskers were set at 1.5 × interquartile range 
(IQR) above the third quartile and 1.5 × IQR below the first quartile, minimum or maximum values that have fallen outside this range are shown as outliers (small 
black dots).
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to sAMCP-delivered antigen in the work reported here (i.e., 
Figure 2) is that the PRR ligand PGN was lacking. Seminal work 
by Blander and Medzhitov examining phagosome maturation 
has described the existence of discrete pathways for handling 
exogenously derived particulate antigen of differing origin at 
the subcellular level. Phagosome-autonomous control of antigen 
presentation dictates that phagosomes containing particulate 
cargo that engages TLRs are favored for MHC class II presenta-
tion. Whereas non-pathogen associated particulate material (i.e., 
devoid of PRR ligands), such as apoptotic cells, is destined to 
follow distinct endosomal pathways, protecting the host from 
the inappropriate presentation of self-antigen (9, 43, 44). Thus, 
phagocytosed sAMCP containing the purified protein antigen 
PPD, in the absence of PGN, may be more susceptible to com-
plete phagosomal degradation rather than continuation along the 
MHC class II presentation pathway. Compartmentalized intra-
cellular pathways for phagocytised material are not unique to the 
uptake of apoptotic self and may also have a role in the process-
ing and presentation of exogenous particulate antigen. Several 
groups have reported same particle (same phagosome) delivery 
of antigen and immune stimulant (PRR ligands) are required to 
elicit robust T  cell responses to exogenous particulate antigen 
(40, 45–47). Additional to compartmentalized pathways for 
phagocytosed material, it is also likely that whole protein antigen 
taken up by APCs in nanoparticulate form may result in modi-
fied processing and presentation of the antigenic protein cargo 
itself, compared to the same protein alone or in its native form. 
Degradation of the sAMCP–PPD protein construct may result 
in protein epitopes that may be either inefficiently processed or 
conversely destroyed during the processing steps within APCs. 
FigUre 7 | il-10 and amorphous magnesium-substituted calcium phosphate (aMcP) staining of human ileal lymphoid patches. (a) 63× confocal 
micrographs from tissue sections from three individuals. IL-10 staining is shown in red and AMCP nanomineral staining in green. Staining is localized to cells residing 
with the sub-epithelial dome of ileal lymphoid patches, nuclear staining is shown in blue. Scale bars—50 μm. (B) Increased magnifications of area’s bounded by 
yellow boxes within the micrographs shown.
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Variations occurring at the MHC II loading compartments may 
result in the presentation of sub-optimal or cryptic peptides (48). 
Recent studies suggest that variations in MHC processing and 
presentation pathways apply to innocuous nanomaterials and 
that exploitation of these pathways is possible for therapeutic 
benefit (49, 50). While such studies support our observations, 
further investigations are required to fully delineate the cellular 
handling of sAMCP, the processing and presentation of its cargo 
and the influence of both PRR and NOD ligands on this process, 
in health and disease.
Our data show that loading synthetic AMCP with T  cell 
antigen in combination with bacterial PGN also fails to 
potentiate immune responses to CD4+ T cell antigen. Instead, 
through the modulation of cell surface MHC expression and 
IL-10 secretion the sAMCP–antigen–PGN construct markedly 
reduces antigen-specific CD4+ T  cell responses. MHC class II 
molecules are constitutively expressed by professional APC, but 
expression is further modulated by multiple agents associated 
with immune responses. The downregulation of cell surface 
MHC II molecules is understood to be one mechanism by 
which IL-10 suppresses adaptive immune responses (51, 52). 
In addition, the instruction of cell surface PD-L1 expression 
might also determine the type of T  cell that proliferates, and 
may favor regulatory over inflammatory T cells (26, 27). In the 
intestine, recognition of resident microbiota via PRRs appears 
a seminal feature in the maintenance of tolerance, as well as 
the development of inflammatory disease in susceptible indi-
viduals (14–18). The intestine lymphoid patches and mesenteric 
lymph nodes are both sites where AMCP+ cells are observed 
in vivo—presumably arriving at the latter via the former. This 
work demonstrates the importance of IL-10 in determining the 
extent of T cell immune responsiveness to luminal derived anti-
gen delivered via nanominerals under steady state conditions. 
Recognition and cellular handling of bacterial components 
carried by AMCP intestinal nanomineral appear an important 
part of the apparent immuno-regulatory feature of intestinal 
nanominerals. Defects in the bacterial sensing receptor NOD-2 
and polymorphisms in genes associated with the intracellular 
handling of bacteria, or their components for processing and 
MHC class II presentation are associated with the development 
of CD. Interruption of these processes may heavily influence or 
even disrupt the intestinal nanomineral pathway (19). Defective 
recognition of the microbial component PGN via the NOD-2 
moiety muramyl dipeptide results in a failure to upregulate 
the immuno-inhibitory receptor PD-L1, observed in vitro and 
in situ in CD intestinal lymphoid tissue, importantly, exhibited 
specifically by nanomineral-bearing APCs residing in Peyer’s 
Patches (25, 29). Our findings further exemplify the inert, 
silent nature of AMCP intestinal nanominerals, which appear 
to act as chaperones for the codelivery of protein antigen and 
bacterial components in the context of T helper cell responses. 
Increasing research strategies exploring the use of nanoparticle 
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based delivery systems designed for immunotherapeutic ben-
efit, such as allergen immunotherapy (53, 54) together with this 
current study, continue to demonstrate the broad potential for 
the application of nanoparticulate dual delivery systems.
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